Report Detail

Pharma & Healthcare Dynamics in Post-pandemic Global Gabapentin (Prescription Drug) Industry: Supply and Demand, Markets and Prices 2021-2027

  • RnM4305043
  • |
  • 13 April, 2021
  • |
  • Global
  • |
  • 132 Pages
  • |
  • GRD Survey
  • |
  • Pharma & Healthcare

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Gabapentin (Prescription Drug) Market Status and Forecast (2016-2027)
      • 1.3.2 Global Gabapentin (Prescription Drug) Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Gabapentin (Prescription Drug) Supply by Company

    • 2.1 Global Gabapentin (Prescription Drug) Sales Volume by Company
    • 2.2 Global Gabapentin (Prescription Drug) Sales Value by Company
    • 2.3 Global Gabapentin (Prescription Drug) Price by Company
    • 2.4 Gabapentin (Prescription Drug) Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Gabapentin (Prescription Drug) Market Status by Category

    • 3.1 Gabapentin (Prescription Drug) Category Introduction
      • 3.1.1 Capsule
      • 3.1.2 Tablet
    • 3.2 Global Gabapentin (Prescription Drug) Market by Category
      • 3.2.1 Global Gabapentin (Prescription Drug) Sales Volume by Category (2016-2021)
      • 3.2.2 Global Gabapentin (Prescription Drug) Sales Value by Category (2016-2021)
      • 3.2.3 Global Gabapentin (Prescription Drug) Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Gabapentin (Prescription Drug) Market Status by End User/Segment

    • 4.1 Gabapentin (Prescription Drug) Segment by End User/Segment
      • 4.1.1 Epilepsy
      • 4.1.2 Neuropathic Pain
      • 4.1.3 Restless Legs Syndrome
      • 4.1.4 Others
    • 4.2 Global Gabapentin (Prescription Drug) Market by End User/Segment
      • 4.2.1 Global Gabapentin (Prescription Drug) Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Gabapentin (Prescription Drug) Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Gabapentin (Prescription Drug) Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Gabapentin (Prescription Drug) Market Status by Region

    • 5.1 Global Gabapentin (Prescription Drug) Market by Region
      • 5.1.1 Global Gabapentin (Prescription Drug) Sales Volume by Region
      • 5.1.2 Global Gabapentin (Prescription Drug) Sales Value by Region
    • 5.2 North America Gabapentin (Prescription Drug) Market Status
    • 5.3 Europe Gabapentin (Prescription Drug) Market Status
    • 5.4 Asia Pacific Gabapentin (Prescription Drug) Market Status
    • 5.5 Central & South America Gabapentin (Prescription Drug) Market Status
    • 5.6 Middle East & Africa Gabapentin (Prescription Drug) Market Status

    6 North America Gabapentin (Prescription Drug) Market Status

    • 6.1 North America Gabapentin (Prescription Drug) Market by Country
      • 6.1.1 North America Gabapentin (Prescription Drug) Sales Volume by Country (2016-2021)
      • 6.1.2 North America Gabapentin (Prescription Drug) Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Gabapentin (Prescription Drug) Market Status

    • 7.1 Europe Gabapentin (Prescription Drug) Market by Country
      • 7.1.1 Europe Gabapentin (Prescription Drug) Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Gabapentin (Prescription Drug) Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Gabapentin (Prescription Drug) Market Status

    • 8.1 Asia Pacific Gabapentin (Prescription Drug) Market by Country
      • 8.1.1 Asia Pacific Gabapentin (Prescription Drug) Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Gabapentin (Prescription Drug) Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Gabapentin (Prescription Drug) Market Status

    • 9.1 Central & South America Gabapentin (Prescription Drug) Market by Country
      • 9.1.1 Central & South America Gabapentin (Prescription Drug) Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Gabapentin (Prescription Drug) Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Gabapentin (Prescription Drug) Market Status

    • 10.1 Middle East & Africa Gabapentin (Prescription Drug) Market by Country
      • 10.1.1 Middle East & Africa Gabapentin (Prescription Drug) Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Gabapentin (Prescription Drug) Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Gabapentin (Prescription Drug) Distributors
    • 11.3 Gabapentin (Prescription Drug) Buyers

    12 Global Gabapentin (Prescription Drug) Market Forecast by Category and by End User/Segment

    • 12.1 Global Gabapentin (Prescription Drug) Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Gabapentin (Prescription Drug) Forecast by Category
      • 12.2.1 Global Gabapentin (Prescription Drug) Sales Volume Forecast by Category
      • 12.2.2 Global Gabapentin (Prescription Drug) Sales Value Forecast by Category
      • 12.2.3 Global Gabapentin (Prescription Drug) Price Forecast by Category
    • 12.3 Global Gabapentin (Prescription Drug) Forecast by End User/Segment
      • 12.3.1 Global Gabapentin (Prescription Drug) Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Gabapentin (Prescription Drug) Sales Value Forecast by End User/Segment
      • 12.3.3 Global Gabapentin (Prescription Drug) Price Forecast by End User/Segment

    13 Global Gabapentin (Prescription Drug) Market Forecast by Region/Country

    • 13.1 Global Gabapentin (Prescription Drug) Market Forecast by Region (2022-2027)
      • 13.1.1 Global Gabapentin (Prescription Drug) Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Gabapentin (Prescription Drug) Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Pfizer
      • 14.1.1 Company Information
      • 14.1.2 Gabapentin (Prescription Drug) Product Introduction
      • 14.1.3 Pfizer Gabapentin (Prescription Drug) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Assertio Therapeutics
      • 14.2.1 Company Information
      • 14.2.2 Gabapentin (Prescription Drug) Product Introduction
      • 14.2.3 Assertio Therapeutics Gabapentin (Prescription Drug) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Jiangsu Hengrui
      • 14.3.1 Company Information
      • 14.3.2 Gabapentin (Prescription Drug) Product Introduction
      • 14.3.3 Jiangsu Hengrui Gabapentin (Prescription Drug) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Marksans Pharma
      • 14.4.1 Company Information
      • 14.4.2 Gabapentin (Prescription Drug) Product Introduction
      • 14.4.3 Marksans Pharma Gabapentin (Prescription Drug) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Glenmark
      • 14.5.1 Company Information
      • 14.5.2 Gabapentin (Prescription Drug) Product Introduction
      • 14.5.3 Glenmark Gabapentin (Prescription Drug) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 Apotex
      • 14.6.1 Company Information
      • 14.6.2 Gabapentin (Prescription Drug) Product Introduction
      • 14.6.3 Apotex Gabapentin (Prescription Drug) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Sailike
      • 14.7.1 Company Information
      • 14.7.2 Gabapentin (Prescription Drug) Product Introduction
      • 14.7.3 Sailike Gabapentin (Prescription Drug) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Arbor Pharma
      • 14.8.1 Company Information
      • 14.8.2 Gabapentin (Prescription Drug) Product Introduction
      • 14.8.3 Arbor Pharma Gabapentin (Prescription Drug) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 Mylan
      • 14.9.1 Company Information
      • 14.9.2 Gabapentin (Prescription Drug) Product Introduction
      • 14.9.3 Mylan Gabapentin (Prescription Drug) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information
    • 14.10 Alkem
      • 14.10.1 Company Information
      • 14.10.2 Gabapentin (Prescription Drug) Product Introduction
      • 14.10.3 Alkem Gabapentin (Prescription Drug) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 Contact Information
    • 14.11 Intas
    • 14.12 Sun Pharmaceutical
    • 14.13 Aurobindo Pharma
    • 14.14 Amneal
    • 14.15 Jiangsu Enhua
    • 14.16 Novartis
    • 14.17 TEVA

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Gabapentin (Prescription Drug) market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Gabapentin (Prescription Drug) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Capsule
    Tablet

    Segmented by End User/Segment
    Epilepsy
    Neuropathic Pain
    Restless Legs Syndrome
    Others

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    Pfizer
    Assertio Therapeutics
    Jiangsu Hengrui
    Marksans Pharma
    Glenmark
    Apotex
    Sailike
    Arbor Pharma
    Mylan
    Alkem
    Intas
    Sun Pharmaceutical
    Aurobindo Pharma
    Amneal
    Jiangsu Enhua
    Novartis
    TEVA


    Summary:
    Get latest Market Research Reports on Gabapentin (Prescription Drug). Industry analysis & Market Report on Gabapentin (Prescription Drug) is a syndicated market report, published as Dynamics in Post-pandemic Global Gabapentin (Prescription Drug) Industry: Supply and Demand, Markets and Prices 2021-2027. It is complete Research Study and Industry Analysis of Gabapentin (Prescription Drug) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,980.00
    $4,470.00
    $5,960.00
    2,151.56
    3,227.34
    4,303.12
    2,521.08
    3,781.62
    5,042.16
    327,680.80
    491,521.20
    655,361.60
    221,861.00
    332,791.50
    443,722.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report